ghk-cu peptide science Peptide: Mechanism, Anti-Aging Research, and Regenerative Benefits What Is GHK-Cu? How It

Presented in 5ml sterile ampoules, this formulation provides reliable performance, rapid onset, and controlled dosingideal for trained practitioners delivering injectable or minor surgical aesthetic treatments

BPC-157 adds another dimension by preventing the mitochondrial damage that contributes to mast cell hyperactivation

Solving the crystal structures of MTAN co-crystallized with several inhibitors provided significant information about inhibitor-target interactions, and this is an essential step in exploring the potential of using the transition-state enzyme analogues as antibacterial drugs

Nat Cell Biol

The Phase 2/3 LIFT-AD trial (NCT04488419), evaluating once-daily subcutaneous fosgonimeton 40 mg versus placebo in 312 participants with mild-to-moderate Alzheimers disease over 26 weeks, failed its primary endpoint (Global Statistical Test composite of ADAS-Cog11 and ADCS-ADL23) and its key secondary endpoints when results were announced in September 2024